Anthropic IPO turns away mainland China, Hong Kong orders

Anthropic's initial public offering is shutting out institutional investors in mainland China and Hong Kong. Citing several people familiar with the matter, Bloomberg reports that some underwriting banks have either flatly refused subscription orders from clients in the two regions or concluded that such orders are unlikely to receive any allocation. Some of the sources point to the U.S. International Traffic in Arms Regulations (ITAR) as the reason. Anthropic declined to comment, and lead underwriters Goldman Sachs and Morgan Stanley did not respond.

Based on deal terms Bloomberg reviewed, the IPO is set to price on November 18 U.S. time and list the next day on the Nasdaq Global Select Market under the ticker ANT. Goldman Sachs and Morgan Stanley are leading the deal, with 20 other banks participating. Anthropic and its co-founders plan to raise up to $90.4 billion in total through the IPO and a private placement, implying a valuation of about $1.4 trillion. People familiar with the matter say indications of interest currently stand at roughly six times the shares on offer.

Illustration: a red barrier blocks IPO envelopes as one takes a side route, suggesting indirect access attempts

Where the block lives

The restriction has not been put in writing. Anthropic's offering documents list the United States, Australia, Canada, Japan, Switzerland, the United Kingdom and some European Economic Area countries as places where the shares will be offered, and say underwriters may also sell outside those jurisdictions. What they do not do is single out mainland China and Hong Kong for any sales restriction.

According to the people familiar, the New York underwriting team handling Anthropic's allocation has said in verbal communications that ITAR bars investors in the China region from taking part. The banks have not stopped clients from submitting orders, nor stopped sales teams from entering orders on clients' behalf; the problem comes after submission, when it is decided whether an order is allocated any stock. China appears on the U.S. defense trade control list alongside North Korea and Iran, which is the background that makes ITAR citable. Whether it applies by law to an ordinary share offering by an AI company, however, is a question for which no written explanation from a regulator or the company has surfaced.

Bloomberg's report adds that Anthropic's roadshow materials were viewable normally in Hong Kong on Friday, but the list of authorized distributors includes no Hong Kong retail brokerage.

SpaceX took the same route

The same treatment has already appeared once this year. In SpaceX's $86.2 billion IPO, Citigroup, which handled international distribution, told syndicate members that under ITAR it would not accept orders from buyers in mainland China and Hong Kong; in June, SpaceX's website could not even be reached from Hong Kong. The retail offering footprints of the two deals are also similar, with Asia-Pacific opened only to a handful of countries such as Australia and Japan.

The difference is that SpaceX builds rockets and satellites, a textbook defense-related business. Anthropic's products were never available in mainland China or Hong Kong to begin with, and the company recently restricted people traveling to those two places from using Claude. It is also caught up in a lawsuit with the Pentagon: the U.S. Department of Defense has labeled it a national security supply chain risk, and last month the Trump administration asked an appeals court to overturn a ruling that lifted a ban on federal agencies using its products. The risk factors section of the prospectus also says the U.S. government is stepping up scrutiny of AI companies' dealings with Chinese state actors.

What it means for Chinese-market investors

Money that wants in has not simply walked away. One person familiar says the family office of a Chinese tech company founder is placing an order through a trust registered in the British Virgin Islands, with the outcome still unclear; other investors are looking at indirect exposure through special purpose vehicles (SPVs) and swap contracts. Hong Kong investors may also submit subscriptions through offshore holding structures.

Whether these routes work is up to the issuer. The people familiar say that Anthropic and the underwriters decide who gets allocations, and that such matters are generally not set out in formal written guidance. An offshore structure may get an order submitted, but not necessarily shares.

The SpaceX precedent points to another possibility: investors in both regions were kept out of that IPO but could still buy in the secondary market after listing. If Anthropic follows the same approach, capital from the Chinese market would not get the offer price but could buy at market price after trading opens on November 19. Neither the company nor the underwriters has said whether secondary-market trading after the listing will face any further restrictions.

Sources: Bloomberg's reporting on the underwriting syndicate's allocation arrangements, CocoLoop, The Economic Times syndicated copy; offering regions, ticker and pricing date follow the deal terms Bloomberg reviewed, and the total raise reflects the IPO and private placement combined.